Detalhe da pesquisa
1.
Consensus of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy (ABHH) and the Brazilian Ministry of Health - General management of blood and blood products on the tests necessary for the release of exceptional medicines for sickle cell disease.
Hematol Transfus Cell Ther
; 46(1): 67-71, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326179